🇺🇸 FDA
Patent

US 9193739

Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization

granted A61KA61K2039/505A61K31/439

Quick answer

US patent 9193739 (Induction of highly specific antibodies to a hapten but not to a carrier peptide by immunization) held by The United States of America as Represented by the Secretary, Dept. of Health and Human Services expires Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Nov 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61K, A61K2039/505, A61K31/439, A61K31/485, A61K47/646